Subsequently, Gutova et al. reported that in six small cell lung cancer cell lines, the clonal expression of uPAR is associated to multidrug resistance, high clonogenic activity and co-expression of CD44 and MDR1, putative cancer stem cell markers. The gene discussed is PLAUR; the disease is cancer.